Skip to main content

Table 4 Organ absorbed doses for ICRP 133 standard man and standard woman

From: Human biodistribution and internal dosimetry of 4-[ 18F]fluorobenzyl-dexetimide: a PET radiopharmaceutical for imaging muscarinic acetylcholine receptors in the brain and heart

Target organsAbsorbed dose (μGy/MBq)
 Male (N = 2)Female (N = 3)
Lungs42.14±7.1640.93±3.11
Stomach wall17.05±2.9717.89±4.18
Colon8.74±0.179.16±1.11
Red marrow14.68±2.6720.03±2.89
Breast6.95±0.566.71±0.74
Ovaries   11.27±1.24
Testes3.75±0.07   
Thyroid16.95±2.1138.60±28.72
Oesophagus13.49±1.8913.74±1.63
Urinary bladder wall23.23±6.3732.63±4.15
Liver52.91±1.4661.66±13.61
Endosteum7.63±1.2010.56±1.37
Skin3.43±0.134.00±0.66
Brain27.35±5.1833.17±0.44
Salivary glands4.02±0.475.41±0.46
Adrenals17.99±0.1822.34±3.84
Extrathoracic tissue5.59±0.756.66±0.63
Gallbladder wall27.27±0.7029.44±5.98
Heart wall43.94±12.8839.33±5.06
Kidneys27.24±0.2731.01±1.88
Lymphatic nodes9.77±0.4510.45±1.27
Muscle7.91±0.1011.54±0.77
Oral mucosa4.08±0.505.12±0.48
Pancreas15.44±0.1314.90±2.54
Prostate11.19±2.08   
Small intestine9.82±0.7412.03±1.59
Spleen36.44±7.4139.69±8.29
Thymus9.16±1.5110.08±0.89
Uterus/cervix   15.72±1.80
  1. Each datum is the sample mean ± sample 95%CI of the organ doses taken over all subjects of the same sex